It's widely understood that prescription drug costs in the United States are too high. But what’s behind the high prices, and how could Congress and the administration take on drug pricing in the current environment? The Commonwealth Fund recently convened three experts to address these questions in an informational briefing. Read the transcript or listen to the recording to learn more.
